参考文献/References:
[1] 郑春松,林珠灿,许惠风,等.透骨消痛胶囊治疗骨性关节炎的多向药理学研究[J].福建中医药大学学报,2011,21(1):43-47.
[2] 吴追乐,李西海,吴广文,等.透骨消痛胶囊含药血清对软骨细胞线粒体凋亡通路的影响[J].中华中医药杂志,2011,26
(2):343-346.
[3] 刘伯龄,梁珪清,高雪伟,等.透骨消痛胶囊干预膝骨性关节炎早期COX-2炎症途径的实验研究[J].福建中医药大学学
报,2011,21(4):13-15.
[4] 李民,陈文列,刘献祥,等.透骨消痛胶囊干预膝骨性关节炎软骨下骨重塑分子机制探讨[J].福建中医学院学报,2009,19
(6):35-39.
[5] 徐淑云,卞如濂,陈修.药理实验学方法[M].3版.北京:人民卫生出版社,2002:202.
[6] Li XH,Wu MX,Ye HZ,et al.Experimental study on the suppression of sodium nitroprussiate-induced chondrocyte
apoptosis by Tougu Xiaotong Capsule-containing serum[J].Chin J Integr Med,2011,17(6):436-443.
[7] Hulit J,Lee RJ,Russell RG,et al.ErbB-2-induced mammary tumor growth:the role of cyclin D1 and p27kip1
[J].Biochem Pharmacol,2002,64(5-6):827-836.